Acetylation of MKP-1 and the control of inflammation.
D000107:Acetylation / Q000187:drug effects; D000818:Animals; D015551:Autoimmunity / Q000187:drug effects; D042002:Chromatin Assembly and Disassembly / Q000187:drug effects / Q000276:immunology*; D016207:Cytokines / Q000096:biosynthesis / Q000276:immunology*; D054638:Dual Specificity Phosphatase 1 / Q000276:immunology* / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000276:immunology / Q000494:pharmacology; D056572:Histone Deacetylase Inhibitors; D006655:Histone Deacetylases / Q000276:immunology / Q000378:metabolism; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects; D007249:Inflammation / Q000188:drug therapy / Q000201:enzymology / Q000276:immunology; D018836:Inflammation Mediators / Q000276:immunology* / Q000378:metabolism; D048031:JNK Mitogen-Activated Protein Kinases / Q000276:immunology / Q000378:metabolism; D010766:Phosphorylation / Q000187:drug effects / Q000276:immunology; D018805:Sepsis / Q000188:drug therapy / Q000201:enzymology / Q000276:immunology; D051193:Toll-Like Receptors / Q000276:immunology / Q000378:metabolism; D048051:p38 Mitogen-Activated Protein Kinases / Q000276:immunology / Q000378:metabolism
D016207:Cytokines; D004791:Enzyme Inhibitors; D056572:Histone Deacetylase Inhibitors; D018836:Inflammation Mediators; D051193:Toll-Like Receptors; D048031:JNK Mitogen-Activated Protein Kinases; D048051:p38 Mitogen-Activated Protein Kinases; C517019:DUSP1 protein, human; D054638:Dual Specificity Phosphatase 1; D006655:Histone Deacetylases